Herbal Medicine Fights Malaria

A growing number of African countries where drug-resistant malaria is spreading are turning to artemisinin, an extract from sweet wormwood that has been used as herbal medicine in China for more than 1,000 years.

An estimated 30 million malaria cases will be treated in 2004 with artemisinincombination therapy or ACT, and demand is expected to rise to 180 million by 2006, according to the Global Fund for AIDS, Tuberculosis and Malaria, which has provided
some poor countries with the drug.

“Implementation of ACT in Africa is an enormous challenge to pharmaceutical companies,
policymakers, and the international health community,” said Mary Ettling, USAID malaria team leader.

“Obtaining supplies of ACT is only a small part of the job. The tough part is distributing the drug to all communities and ensuring that it is used correctly by patients,” she said.

USAID has supported safety and efficacy testing of ACT in Africa since 1998. Support increased recently, as the drug was found safe and effective when used by children.

As drug-resistant malaria spread, USAID quadrupled funding to fight the disease: from $22 million in 1998 to $83 million in 2004. In the past three years, the U.S. government contributed $623 million to the Global Fund and is giving up to $547 million this year.

Malaria kills 1 million people worldwide each year, making it the world’s third deadliest infectious disease. An estimated 300 million to 500 million people are ill with malaria annually, while new AIDS and tuberculosis infections attack 5.3 million and 8.8 million respectively, according to the World Health Organization (WHO).

In Africa, malaria is most common in children and pregnant women.

USAID also supports the use of insecticide-treated mosquito nets, which can reduce overall child mortality by as much as 25–30 percent. The Agency also funds the development of a malaria vaccine that is being field tested in Kenya and Mali.

Access the June 2004 edition of FrontLines [PDF, 1.4MB]